Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23033594 | 0.85 | ADRA2A (0.48) | TP53MAPTRAB9AHDAC6MAOB | |
| SCHEMBL23012217 | 0.81 | MAOB (0.57) | MAPTRAB9ASMN1; SMN2MAOAMAOB | |
| SCHEMBL23012299 | 0.80 | RAB9A (0.69) | TP53MAPTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL29479664 | 0.77 | GSK3B (0.45) | — | |
| SCHEMBL23012523 | 0.77 | GSK3B (0.45) | — | |
| SCHEMBL28695261 | 0.77 | APP (0.41) | APPHDAC6MAOAMAOBMAPK1 | |
| SCHEMBL1336313 | 0.75 | ALDH1A1 (0.50) | MAPTALDH1A1GAAMAPK1 | |
| SCHEMBL211674 | 0.74 | FLT3 (0.67) | TP53MAPTRAB9ASMN1; SMN2FLT3 | |
| Hydrochloric Acid SCHEMBL31345624 | 0.74 | ALDH1A1 (0.49) | MAPTALDH1A1GAAMAPK1 | |
| SCHEMBL30800091 | 0.73 | ALDH1A1 (0.54) | TP53MAPTALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114269725-B | Anti-influenza virus compound, preparation method and application thereof | 西藏海思科制药有限公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-114269725-A | Anti-influenza virus compound and preparation method and application thereof | 四川海思科制药有限公司 | 2022-04-01 | — | — | CN | disclosed |
| WO-2021032209-A1 | ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF | 四川海思科制药有限公司 | 2021-02-25 | — | — | WO | disclosed |
| WO-2021032209-A1 | ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF | 四川海思科制药有限公司 | 2021-02-25 | — | — | WO | disclosed |